Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIIA Stage Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00310154
What this trial is testing

Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 45
Large-scale testing (Phase 3)Enrolling By InvitationNCT04762459
What this trial is testing

Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Who this might be right for
Non-small Cell Lung Carcinoma
Chinese Academy of Medical Sciences 606
Testing effectiveness (Phase 2)UnknownNCT00886405
What this trial is testing

Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced Non Small-Cell Lung Canger
National Institute of Cancerología 40
Testing effectiveness (Phase 2)UnknownNCT02820116
What this trial is testing

The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Beijing Haidian Hospital 67
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT04229381
What this trial is testing

Resiliency Among Older Adults Receiving Lung Cancer Treatment

Who this might be right for
Advanced Lung CarcinomaExtensive Stage Lung Small Cell CarcinomaStage IIIA Lung Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00408499
What this trial is testing

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 64
Large-scale testing (Phase 3)UnknownNCT00139971
What this trial is testing

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
West Japan Thoracic Oncology Group 600
Testing effectiveness (Phase 2)Looking for participantsNCT06987734
What this trial is testing

Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03637816
What this trial is testing

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
AnorexiaLung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 25
Not applicableActive Not RecruitingNCT03939481
What this trial is testing

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+43 more
SWOG Cancer Research Network 1,336
Large-scale testing (Phase 3)UnknownNCT00022009
What this trial is testing

Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02823990
What this trial is testing

TG4010 and Nivolumab in Patients With Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage II Non-Small Cell Lung Cancer+3 more
Megan Daly, MD 13
Large-scale testing (Phase 3)Looking for participantsNCT04267848
What this trial is testing

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Who this might be right for
Lung Non-Small Cell CarcinomaLung Non-Small Cell Squamous CarcinomaLung Non-Squamous Non-Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 1,210
Early research (Phase 1)Active Not RecruitingNCT04013542
What this trial is testing

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

Who this might be right for
ALK Gene RearrangementEGFR Gene MutationLocally Advanced Lung Non-Small Cell Carcinoma+9 more
M.D. Anderson Cancer Center 21
Not applicableStudy completedNCT05339022
What this trial is testing

Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaAdvanced Lung Small Cell CarcinomaExtensive Stage Lung Small Cell Carcinoma+7 more
Ohio State University Comprehensive Cancer Center 100
Large-scale testing (Phase 3)Ended earlyNCT00738881
What this trial is testing

Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Ended earlyNCT00856427
What this trial is testing

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Who this might be right for
Lung Cancer
Virginia Commonwealth University 6
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Next Page